Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12618001479291
ACTRN12618001479291
Active, not recruiting
未知

Comparisons of human embryonic development in culture medium with and without antioxidant supplementation

Melbourne IVF0 sites1,482 target enrollmentSeptember 4, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsinfertilityReproductive Health and Childbirth - Fertility including in vitro fertilisation

Overview

Phase
未知
Intervention
Not specified
Conditions
infertility
Sponsor
Melbourne IVF
Enrollment
1482
Status
Active, not recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 4, 2018
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Couples with female, male or unexplained infertility intending to undergo IVF or ICSI and where there are no medical contraindications to perform the treatment.
  • •The couple should have received verbal and written information/consent about the study.
  • •Blastocyst culture and fresh transfer on day 5 of a single embryo.
  • •Concomitant medications (eg; use of any oral antioxidants) will be recorded

Exclusion Criteria

  • •Previous participation in the study.
  • •Use of PGS where frozen embryo transfer is planned
  • •Testicular biopsy patients (TESA/TESE)
  • •Total freeze and no transfer possible.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Comparison of Human Embryo Development Using Sequential and Single Media With Time-lapse ImagingInfertility
NCT01939626Vitrolife128
Completed
Phase 1
In Vitro Human Embryo Culture SystemInfertility
NCT00985218Incept BioSystems, Inc.40
Completed
Not Applicable
Evaluation of a Closed Assisted Reproductive Technology (ART) Station Versus an Open Flow CabinetART
NCT03343938IVI Sevilla78
Completed
Not Applicable
The effect of different media for sperm handling and injection at intracytoplasmic sperm injection (ICSI) on subsequent embryo cleavage: a comparison of the use of polyvinylpyrrolidone (PVP) and hyaluronan.InfertilityReproductive Health and Childbirth - Fertility including in vitro fertilisation
ACTRN12613000957796Fertility North60
Active, not recruiting
Not Applicable
Clinical study to compare recombinant human growth hormone Cristalia(r-hGH Cristalia) versus Genotropin® in prepubertal children withgrowth deficiency due to deficiency of growth hormone.Growth deficiency due to growth hormone deficiencyMedDRA version: 18.1Level: PTClassification code 10056438Term: Growth hormone deficiencySystem Organ Class: 10014698 - Endocrine disordersTherapeutic area: Diseases [C] - Hormonal diseases [C19]
EUCTR2016-000446-56-Outside-EU/EEACristália Produtos Químicos Farmacêuticos Ltda.94